Insulin Resistance May Lead to Kidney Disease in the
THURSDAY, March 8 (HealthDay News) -- Elderly people with
metabolic syndrome are at increased risk for chronic kidney
disease, and insulin resistance may be the central hub that links
metabolic syndrome and kidney-function decline, according to a new
People are diagnosed with metabolic syndrome when they have at
least three risk factors for diabetes and heart disease, including:
high blood pressure, high blood-sugar (glucose) levels, high
triglycerides (fat in the blood), low levels of "good" (HDL)
cholesterol and too much abdominal fat.
The study included 1,456 people, aged 65 and older, in Taiwan
who were followed for an average of more than three years. The
findings will appear in the
Journal of Clinical Endocrinology & Metabolism.
"Our study found that metabolic syndrome predicts both the prevalence and incidence of chronic kidney disease in people aged 65 years or older," the lead investigator, Dr. Chung-Jen Yen, of National Taiwan University in Taipei, said in a journal news release.
"We also found that rapid decline in renal function is more likely found in individuals with insulin resistance and high blood-sugar levels," Yen added.
The findings suggest "that people can safeguard their kidneys
when they take care of their blood glucose levels and lose weight,"
Yen said. "Further studies are needed to assess the impact of
treating metabolic syndrome and insulin resistance on renal
outcomes in the elderly population."
The American Academy of Family Physicians has more about
Copyright © 2012
. All rights reserved.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.